Bexarotene
NDC Package 43602-176-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Bexarotene is used to treat skin problems from a certain type of cancer (cutaneous T-cell lymphoma-CTCL). Marketed by Ascent Pharmaceutical Inc, this product is identified by NDC 43602-176 and is authorized under FDA application ANDA208628.

Identification & Billing

NDC Package Code
43602-176-01
Package Description
1 BOTTLE in 1 CARTON / 100 CAPSULE in 1 BOTTLE
Product Code
43602-176
11-Digit Billing Format
43602017601

Clinical Specifications

Proprietary Name
Bexarotene
Dosage Form
-
Usage Information
Bexarotene is used to treat skin problems from a certain type of cancer (cutaneous T-cell lymphoma-CTCL). It belongs to a class of drugs called retinoids (vitamin A derivatives). Bexarotene works by slowing or stopping the growth of cells.

Regulatory & Marketing

Labeler Name
Ascent Pharmaceutical Inc
FDA Application #
ANDA208628
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
09-06-2024
End Marketing Date
09-07-2024
Listing Expiration
09-07-2024
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (43602-176). Click a package code to view its specific billing and regulatory data.

43602-176-05
1 BOTTLE in 1 CARTON / 500 CAPSULE in 1 BOTTLE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 43602-176-01 identifies a specific commercial package of 1 bottle in 1 carton / 100 capsule in 1 bottle of Bexarotene, labeled by Ascent Pharmaceutical Inc. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Ascent Pharmaceutical Inc on September 06, 2024. The current certification is valid through September 07, 2024.

What are the primary indications for this medication?

Bexarotene is used to treat skin problems from a certain type of cancer (cutaneous T-cell lymphoma-CTCL). It belongs to a class of drugs called retinoids (vitamin A derivatives). Bexarotene works by slowing or stopping the growth of cells.

How is this Ascent Pharmaceutical Inc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 43602017601. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
43602-176-01
11-Digit CMS (5-4-2)
43602-0176-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.